Cargando…
The Potential of MicroRNAs as Clinical Biomarkers to Aid Ovarian Cancer Diagnosis and Treatment
Ovarian cancer is a commonly diagnosed malignancy in women. When diagnosed at an early stage, survival outcomes are favourable for the vast majority, with up to 90% of ovarian cancer patients being free of disease at 5 years follow-up. Unfortunately, ovarian cancer is typically diagnosed at an advan...
Autores principales: | Davies, Molly, Davey, Matthew G., Miller, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690044/ https://www.ncbi.nlm.nih.gov/pubmed/36360295 http://dx.doi.org/10.3390/genes13112054 |
Ejemplares similares
-
The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment
por: Davey, Matthew G., et al.
Publicado: (2021) -
In Silico Screening of Circulating MicroRNAs as Potential Biomarkers for the Diagnosis of Ovarian Cancer
por: Wu, Lei, et al.
Publicado: (2019) -
Biological Implications of MicroRNAs as Regulators and Biomarkers of Therapeutic Toxicities in Breast Cancer
por: Abbas Syed, Raza, et al.
Publicado: (2023) -
MicroRNAs as Biomarkers for Early Diagnosis, Prognosis, and Therapeutic Targeting of Ovarian Cancer
por: Mirahmadi, Yegane, et al.
Publicado: (2021) -
MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers
por: Sharma, Prakash Chand, et al.
Publicado: (2020)